1206MO ALINA: Exploratory biomarker analyses in patients (pts) with resected ALK+ non-small cell lung cancer (NSCLC) treated with adjuvant alectinib vs chemotherapy (chemo)

Autor: Solomon, B.J., Wu, Y-L., Dziadziuszko, R., Barlesi, F., Nishio, M., Ahn, J.S., Horinouchi, H., Hochmair, M.J., de Marinis, F., Migliorino, M.R., Kurochkin, A., Harputluoglu, H., Planchard, D., Korphaisarn, K., Han, J-Y., Lohmann, T., Cardona Gavaldon, A., Archer, V.R., Nowicka, M., Noe, J.

Publikováno v: In Annals of Oncology September 2024 35 Supplement 2:S775-S775

The role of mitomycin C in the treatment of patients with advanced colorectal cancer resistant to 5-fluorouracil-folinic acid chemotherapy

Autor: Grumett, S.A., Archer, V.R., Midgley, R., Mulholland, P., Nicum, S., Blewitt, L., Kerr, D.J.

Publikováno v: In Annals of Oncology April 2001 12(4):575-575

Palliative Chemotherapy: No Longer a Contradiction in Terms

Autor: Archer, V.R., Billingham, L.J., Cullen, M.H.

Publikováno v: Oncologist; December 1999, Vol. 4 Issue: 6 p470-477, 8p

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

629MO ALESIA 7-year update: Alectinib vs crizotinib in Asian patients (pts) with treatment-naïve advanced ALK+ non-small cell lung cancer (NSCLC).

Autor: Zhou, C.¹ (AUTHOR), Lu, Y.² (AUTHOR), Kim, S-W.³ (AUTHOR), Baisamut, T.R.⁴ (AUTHOR), Zhou, J.⁵ (AUTHOR), Zhang, Y.⁶ (AUTHOR), He, J.⁷ (AUTHOR), Yang, J-J.⁸ (AUTHOR), Cheng, Y.⁹ (AUTHOR), Lee, S-H.¹⁰ (AUTHOR), Chang, J.¹¹ (AUTHOR), Fang, J.¹² (AUTHOR), Liu, Z.¹³ (AUTHOR), Bu, L.¹⁴ (AUTHOR), Qian, L.¹⁵ (AUTHOR), Archer, V.R.¹⁶ (AUTHOR), Zhou, M.¹⁷ (AUTHOR), Zhang, L.¹⁸ (AUTHOR)

Publikováno v: Annals of Oncology. 2024 Supplement 4, Vol. 35, pS1634-S1635. 2p.